Leukotrienes antagonize the antiproliferative effect of Larrea divaricata Cav. on a lymphoma cell line interfering with cAMP intracellular level and PKC activity

Cancer Investigation

Volumn 29, Issue 1, 2011, Pages 29-36

  Davicino, Roberto ^a   Genaro, Ana Maria ^b   Cremaschi, Graciela ^b   Anesini, Claudia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Cyclic adenosine monophosphate; L. divaricata; LTB4; Lymphoma BW5147; Protein kinase C

Indexed keywords

CYCLIC AMP; LARREA DIVARICATA EXTRACT; LEUKOTRIENE B4; PLANT EXTRACT; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LARREA DIVARICATA; LYMPHOMA CELL LINE; MEDICINAL PLANT; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; LARREA; LEUKOTRIENE B4; LYMPHOMA, T-CELL; MICE; PLANT EXTRACTS; PLANT LEAVES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; UP-REGULATION;

EID: 78650495911     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.535058     Document Type: Article

References (41)

1. Anesini C, Genaro A, Cremaschi G, Sterin Borda L, Cazux C, Borda E. Immunomodulatory activity of Larrea divaricata Cav. Fitoterapia 1996;67(4):329-334.
2. Anesini C, Genaro A, CremaschiG, Boccio J, ZubillagaM, Sterin Borda L, Borda E. 'In vivo' antitumor activity of Larrea divaricata Cav. Comparison of two routes of administration extract. Phytomedicine 1998;5:41-45.
3. Anesini C, Genaro A, CremaschiG, Zubillaga M, Boccio J, Sterin Borda L, Borda E. 'In vivo' and 'in vitro' antitumoral action of Larrea divaricata Cav. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana 1996;46(1):33-40.
4. Anesini C, Genaro A, Cremaschi G, Sterin Borda L, Borda E. Antimitogenic effect of Larrea divaricata Cav.: participation in arachidonate metabolism. Comp Biochem Physiol Part C 1999; 122(2):245-252.
5. Nishizuka Y.Themolecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988;334:661-665.
6. Parker PJ, Kour G, Marais RM, Mitchell F, Pears C, Schaap D, Stabel S, Webster C. Protein kinase C-a family affair. Mol Cell Endocrinol 1989;65(1-2):1-11.
7. Kennedy MJ, Prestigiacomo LJ, Tyler G, Mayand WS, Davidson NE. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res 1992;5:1278-1283.
8. Kolivunen J, Aaltonen V, Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Lett 2006;235(1):1-10.
9. Dumont JE, Jauniaux JC, Roger PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 1989;14(2):67-71.
10. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 2002;12(6):258-266.
11. Van Oirschot BA, Stahl M, Lens SM, Medema RH. Protein kinaseAregulates expression of p27(kip1) and cyclinD3 to suppress proliferation of leukemic T cell lines. J Biol Chem 2001;276(36):33854-33860.
12. Stege P, Davicino R, Vega A, Casali Y, Correa S, Micalizzi B. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav. (Jarilla) against Helicobacter pylori. Phytomedicine 2006;13(9-10):724-727.
13. Davicino R,Mattar A, Casali Y, Porporatto C, Correa S,Micalizzi B. Activation and apoptosis of mouse peritoneal macrophages by extracts of Larrea divaricata Cav. (Jarilla). Int Immunopharmacol 2006;13-14(6):2047-2056.
14. Genaro AM, Bosca L. Early signals in alloantigen-induced B-cell proliferation. J Immunol 1993;151(4):1832-1843.
15. Junco, M, Diaz-Guerra MJM, Bosca L. Substrate-dependent inhibitors of protein kinase C by specific inhibitors. FEBS Lett 1990;263(1):169-174.
16. Diaz-Guerra MJM, Bosca L. Lack of translocation of protein kinaseCfromthe cytosol to themembrane in vasopresin-stimulated hepatocytes. Biochem J 1990;269(1):163-176.
17. Jasuda I, Kishimoto A, Tanaka S, Masahiro T, Sokurai A,Nishizuka A. Synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun 1990;166(3):1220-1227.
18. Edgar VA, Sterin-Borda L, Cremaschi G, Genaro AM. Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur J Pharmacol 1999;372(1):65-73.
19. Shimizu T, Wolfe LS. Arachidonic acid cascade and signal transduction. J Neurochem 1990;55(1):1-15.
20. Vore SJ, Eling TE, Danolowicz M, Turker AN. Regulation of murine hematopoiesis by arachidonic acid metabolites. Int J Immunopharmacol 1989;11(5):435-442.
21. Drazen JM, Austen KF. Leukotrienes and airway responses. Am Rev Respir Dis 1987;136(4):985-998.
22. Ford-Hutchinson AW. Leukotriene B4 in inflammation. Crit Rev Immunol 1990;10:1-12.
23. El-Hakim IE, Langdon JD, Zakrzewski JT, Costello JF. Leukotriene B4 and oral cancer. Br J Oral Maxillofac Surg 1990;28(3):155-159.
24. Bortuzzo C, Hanif R, Kashfi K, Staiano-Coico L, Shift SJ, Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta 1996;1300(3): 240-246.
25. Wei-Gang T, Xian-Zhong D, Talamonti MS, Bell RH, Adrian TE. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res Commun 2005;335(3):949-956.
26. Wei-Gang T, Xian-Zhong D, Adrian TE. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 2002;296(4): 942-948.
27. Wei-Gang T, Xian-Zhong D, Standop WJ, Pour PM, Adrian TE. Leukotriene B4 receptor antagonist LY293111 inhibitsproliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 2002;8(10):3232-3242.
28. Hennig R, Ventura J, Segersvard R, Ward E, Ding XZ, Rao SM, Jovanovic BD, Iwamura T, Talamonti MS, Bell Jr., RH, Adrian TE. LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia 2005;7(4):417-425.
29. Ralph P. Retention of lymphocyte characteristics bymielomas and ? +- lymphomas: sensitivity to cortisol and phytohemagglutinin.J Immunol 1973;110:1470-1475.
30. Estes G, Solomon SS, Norton WL. Inhibition of lymphocyte stimulation by cyclic and non-cyclic nucleotides. J Immunol 1971;107:1489-1492.
31. Katsaros D, Tortora G, Tagliaferri P, Clair T, Ally S, Neckers L, Robins RK,Cho-ChungYS. Site-selective cyclicAMPanalogs provide a newapproach in the control of cancer cell growth. FEBS Lett 1987;223(1):97-103.
32. Tortora G, Clair T, Katsaros D, Ally S, Colamonici O, Neckers LM, Tagliaferri P, Jahnsen T, Robins RK, Cho-Chung YS. Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells. Proc Natl Acad Sci USA 1989;86(8):2849-2852.
33. Cho-Chung YS. Site-selective 8-chloro-cyclic adenosine 3-,5- monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms. J Natl Cancer Inst 1989;81(13): 982-987.
34. Davicino R, Manuele MG, Turner S, Ferraro G, Anesini C. Antiproliferative activity of Larrea divaricata Cav. on a lymphoma cell line: participation of hydrogen peroxide in its action. Cancer Invest 2010;28(1):13-22.
35. Wang S, Gustafson E, Pang L, Qiao X, Behan J, Maguire M, Bayne M, Laz T. A novel hepatointestinal leukotriene B4 receptor: cloning and functional characterization. J Biol Chem2000;275(52):40686-40694.
36. Sporn P, Marshall T, Peters-Golden M. Differential dependence on protein kinase C of arachidonic acid metabolism stimulated by hydrogen peroxide and zymosan in the alveolar macrophage. Biochem Biophys Acta 1990;1074(2):127-135.
37. Anesini C, Ferraro G, Lopez P, Borda E. Different intracellular signals coupled to the antiproliferative action of aqueous crude extract from Larrea divaricata Cav. and nor-dihydroguaiaritic acid on lymphoma cell line. Phytomedicine 2001;8(1):1-7.
38. Young S, Parker PJ, Ullrich A, Stabel S. Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J 1987;244(3):775-779.
39. Yang YM, Wang XX, Chen JZ, Wang SJ, Hu H, Wang HQ. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity. Am J Chin Med 2008;36(3):603-613.
40. KimHY, Yu R, KimJS, KimYK, Sung MK.Antiproliferative crude soy saponin extract modulates the expression of IkappaBalpha, protein kinase C, and cyclooxygenase-2 in human colon cancer cells. Cancer Lett 2004;210(1):1-6.
41. Sánchez-Yague J, Rodríguez M, Hernandez A, Llanillo M. Inhibition of prostaglandin E2 responsive adenylcyclase in embryonal human kidney 293 cells by phorbol esthers. J Lipid Mediat Cell Signal 1995;11(1):25-39.